Windsor John A, Reddy Nageshwar D
Department of Surgery, Auckland Clinical School, University of Auckland, Auckland, New Zealand.
Asian Institute of Gastroenterology, Hyderabad, India.
Clin Transl Gastroenterol. 2017 Jan 12;8(1):e213. doi: 10.1038/ctg.2016.68.
The treatment of painful chronic pancreatitis remains controversial. The available evidence from two randomized controlled trials favor surgical intervention, whereas an endotherapy-first approach is widely practiced. Chronic pancreatitis is complex disease with different genetic and environmental factors, different pain mechanisms and different treatment modalities including medical, endoscopic, and surgical. The widely practiced step-up approach remains unproven. In designing future clinical trials there are some important pre-requisites including a more comprehensive pain assessment tool, the optimization of conservative medical treatment and interventional techniques. Consideration should be given to the need of a control arm and the optimal timing of intervention. Pending better designed studies, the practical way forward is to identify subgroups of patients who clearly warrant endotherapy or surgery first, and to design the future clinical trials for the remainder.
疼痛性慢性胰腺炎的治疗仍存在争议。两项随机对照试验的现有证据支持手术干预,而以内科治疗优先的方法则被广泛应用。慢性胰腺炎是一种复杂的疾病,存在不同的遗传和环境因素、不同的疼痛机制以及包括药物、内镜和手术在内的不同治疗方式。广泛应用的逐步升级方法仍未得到证实。在设计未来的临床试验时,有一些重要的先决条件,包括更全面的疼痛评估工具、优化保守药物治疗和介入技术。应考虑设置对照组的必要性以及最佳干预时机。在有更好设计的研究之前,实际的前进方向是识别出明确需要首先进行内科治疗或手术的患者亚组,并为其余患者设计未来的临床试验。